-
Integrated Genomic, Epigenetic, and Expression Analyses of Ovarian Cancer Cell Lines
Study
EGAS00001002998
-
Genomic profiling of paediatric glioma cell lines
Study
EGAS00001003006
-
Biallelic tumor suppressor loss and DNA repair defects in de novo small cell prostate cancer
Study
EGAS00001003007
-
The evolutionary history of human colitis-associated colorectal cancer
Study
EGAS00001003028
-
Identification of recurrent mutations in Cushing’s disease
Study
EGAS00001003029
-
Patient-derived neuroblastoma model system OHC-NB1
Study
EGAS00001003031
-
Capture Hi-C on Hodgkin lymphoma cell line L-428
Study
EGAS00001003032
-
ChIP-seq data of Hodgkin lymphoma cell line L-428
Study
EGAS00001003033
-
AUBTRG - Whole Exome Sequencing of Diffuse Glioma Samples
Study
EGAS00001003035
-
Exome-wide analysis identifies three low-frequency missense variants associated with pancreatic cancer risk in Chinese populations
Study
EGAS00001003040
-
Evolutionary dynamics of residual disease in human glioblastoma
Study
EGAS00001003043
-
Ewings Sarcoma RNA-Seq
Study
EGAS00001003062
-
CCND1-negative MCL
Study
EGAS00001003060
-
Discriminating Th17.1 cell driven sarcoidosis-like inflammation from relapse after anti-BCMA CAR T cells in multiple myeloma
Study
EGAS00001006133
-
Genomic and transcriptomic profiling of combined hepatocellular and intrahepatic cholangiocarcinoma reveals distinct molecular subtypes
Study
EGAS00001003093
-
Feasibility Study to Identify the Optimal Adjuvant Combination Scheme of Ipilimumab and Nivolumab (OpACIN) in resectable stage III melanoma patients
Study
EGAS00001003099
-
Primary plasma cell leukemia (pPCL) samples were sequenced using the Nimblegen MedExome hybridization capture to detect translocations, copy number changes, and mutations in 20 pPCL samples and patient matched controls.
Study
EGAS00001003104
-
Whole-exome sequencing of extranodal NK/T cell lymphoma
Study
EGAS00001004357
-
Whole exome sequencing of small cell neuroendocrine cancer of the cervix
Study
EGAS00001003142
-
Single cell sequencing of endoscopic biopsies from Barrett's oesophagus and proximal tissue from the normal GI tract
Study
EGAS00001003144
-
DNA Methylation-based diagnostic biomarkers for ESCC in Han Chinese population
Study
EGAS00001003158
-
Tumor-associated preferred end coordinates and somatic variants as signatures of circulating tumor DNA
Study
EGAS00001003160
-
Study the differences at the trascriptome level between iNKT and T cells
Study
EGAS00001003176
-
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma
Study
EGAS00001003178
-
The molecular landscape of glioma in patients with Neurofibromatosis 1.
Study
EGAS00001003186
-
Hyperhaploid Multiple Myeloma
Study
EGAS00001003203
-
Fibroblast heterogeneity drives metastatic spread in breast cancer through distinct mechanisms
Study
EGAS00001003238
-
Characterizing the immune and genome landscapes for osteosarcoma
Study
EGAS00001003247
-
Infiltrative and drug-resistant slow-cycling cells support metabolic heterogeneity in glioblastoma
Study
EGAS00001003251
-
Detection of cell-free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients
Study
EGAS00001003255
-
Paired whole exome sequence of subcutaneous panniculitis-like T-cell lymphoma.
Study
EGAS00001003282
-
Whole Tumor spatial heterogeneity in metastatic melanoma
Study
EGAS00001003292
-
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Study
EGAS00001003306
-
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer RNA-Seq
Study
EGAS00001003307
-
MGA-NUTM1 fusion in high grade spindle cell sarcoma
Study
EGAS00001003341
-
Exome sequencing of a novel cervical cancer cell line
Study
EGAS00001003343
-
CAF-S3 subset in human breast and ovarian cancers
Study
EGAS00001003344
-
Glioma Genomics Committee
Dac
EGAC00001000153
-
Single-cell RNA-seq of immune cells sorted from human melanoma tumors
Study
EGAS00001003363
-
Mutational Patterns in Metastatic Cutaneous Squamous Cell Carcinoma
Study
EGAS00001003370
-
Summary statistics from genome-wide association study in glioma of 12,488 cases and 18,169 controls.
Study
EGAS00001003372
-
Whole genome sequencing of Ewings Sarcoma
Study
EGAS00001003385
-
Hepatocellular carcinoma xenografts established from needle biopsies preserve the characteristics of the originating tumors
Study
EGAS00001003396
-
Deciphering Intratumoral Molecular Heterogeneity in Clear Cell Renal Cell Carcinoma with a Radiogenomics Platform
Study
EGAS00001003846
-
Methylation analysis of plasma DNA informs etiologies of Epstein-Barr virus-associated diseases
Study
EGAS00001003408
-
DAC for seminoma genomic data
Dac
EGAC00001000231
-
Intratumoural Heterogeneity Underlies Distinct Therapy Responses and Treatment Resistance in Glioblastoma
Study
EGAS00001003438
-
Multi-region exome sequencing of lung adenocarcinoma precursors -1
Study
EGAS00001003439
-
Carcinosarcoma Data Access Committee
Dac
EGAC00001000234
-
Clonal architectures predict clinical outcome in clear cell renal cell carcinoma
Study
EGAS00001003447
-
Adenoma to Carcinoma transition in Colorectal Cancer
Study
EGAS00001003468
-
Mutational patterns and regulatory networks in epigenetic subgroups of meningioma (H033)
Study
EGAS00001003481
-
Growth Hormone (GH) -secreting Pituitary Adenoma
Study
EGAS00001003488
-
Predicting brain tumor recurrence: development and validation of a DNA-methylation based nomogram in meningioma
Study
EGAS00001003490
-
High-resolution structural genomics reveals new therapeutic vulnerabilities in glioblastoma
Study
EGAS00001003493
-
Genomic stratification and liquid biopsy in a rare adrenocortical carcinoma (ACC) case, with dual lung metastases
Study
EGAS00001003497
-
Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly diagnosed patients
Study
EGAS00001003539
-
Whole Genome Sequencing Reveals Potential Therapeutic Strategy for Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
Study
EGAS00001003876
-
Evolution of GBM through therapy
Study
EGAS00001003546
-
Genetic modification of primary human B cells to model high-grade lymphoma
Study
EGAS00001003560
-
Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma
Study
EGAS00001003564
-
RNA-sequencing of adult T-cell leukemia/lymphoma samples
Study
EGAS00001003575
-
Cancer-Associated Mutations in Endometriosis without Cancer
Study
EGAS00001003576
-
Analysis of four key cell types (epithelial, fbroblast, myeloid and T cells)
Study
EGAS00001003579
-
Single cell transcriptomic and genomic profiling of carcinogenesis in patients with familial adenomatous polyposis
Study
EGAS00001003598
-
A Phase II Trial of High Dose Interleukin-2 and Multi-site Stereotactic Ablative Radiotherapy for Patients with Metastatic Renal Cell Carcinoma
Study
EGAS00001003605
-
Recapitulation of genetic predisposition to medulloblastoma in human neuroepithelial stem cells
Study
EGAS00001003620
-
WGS of Roma (Romani/Rroma) and European/Romanian individuals from Romania
Study
EGAS00001003624
-
UAMS Smoldering Myeloma Myeloma Sequencing
Study
EGAS00001003629
-
UAMS Smoldering Myeloma Timeline Cohort
Study
EGAS00001003687
-
Analysis of copy number variation landscape of glioma by shallow coverage whole genome sequencing
Study
EGAS00001003690
-
Detecting and tracking circulating tumour DNA copy number profiles during first line chemotherapy in oesophagogastric adenocarcinoma
Study
EGAS00001003695
-
Multi-layered molecular characterization defines prognostic subtypes of lung adenocarcinoma in Asian never-smokers
Study
EGAS00001003705
-
Analysis of the genomic landscape of chemoresistant multiple myeloma
Study
EGAS00001003709
-
ID1 in glioblastoma
Study
EGAS00001003711
-
Infant Glioma Molecular Subtype
Study
EGAS00001003714
-
Cancer and germline exomes consisting of FASTQ paired-end reads from melanoma and lung cancer samples
Study
EGAS00001003723
-
DNA Methylation loss coupled with mitotic cell division promotes immune evasion of tumours with high mutation load
Study
EGAS00001003731
-
Glioblastoma initiating cells are sensitive to histone demethylase inhibition due to epigenetic deregulation
Study
EGAS00001003750
-
Polyomavirus-positive Merkel cell carcinoma derived from a trichoblastoma suggests an epithelial origin of Merkel cell carcinoma
Study
EGAS00001003784
-
Molecular profiling reclassifies adult astroblastoma into known and clinically distinct tumor entities with frequent MAPK pathway alterations
Study
EGAS00001003798
-
'KOREAN' never-smoker female adenocarcinoma RNA-seq
Study
EGAS00001003789
-
Transcriptional changes in GBM through therapy
Study
EGAS00001003790
-
Methylation CYLD cutaneous syndrome
Study
EGAS00001003800
-
Delineating intratumoural heterogeneity and neoantigen-directed immune escape in Esophageal Squamous Cell Carcinoma
Study
EGAS00001003832
-
Genomic Analysis of Primary Plasma Cell Leukemia reveals Complex Structural Alterations and High Risk Mutational Patterns
Study
EGAS00001003834
-
Whole exome sequencing CYLD cutaneous syndrome
Study
EGAS00001003839
-
Targeted sequencing CYLD cutaneous syndrome
Study
EGAS00001003840
-
RNA sequencing CYLD cutaneous syndrome
Study
EGAS00001003841
-
Osteosarcoma mate-pair and RNA-sequencing
Study
EGAS00001003842
-
VIKING Health Study - Shetland
Study
EGAS00001003872
-
Immuno-genomic landscape of osteosarcoma
Study
EGAS00001003887
-
Whole genome and whole transcriptome sequencing of patients diagnosed with angiosarcoma.
Study
EGAS00001003895
-
WES of 2 human osteosarcoma and corresponding cell lines
Study
EGAS00001003923
-
Germline MBD4 Mutations and Predisposition to Uveal Melanoma
Study
EGAS00001003941
-
A Unifying Paradigm for Transcriptional Heterogeneity and Squamous Features in Pancreatic Ductal Adenocarcinoma
Study
EGAS00001003974
-
Sequencing data of multiple sarcoma samples for personalized medicine and endotype identification
Study
EGAS00001003981
-
SCC ctDNA sequencing
Study
EGAS00001003987
-
SCC tumor sequencing
Study
EGAS00001003988
-
MYO5B mutations in Pheochromocytoma/Paraganglioma promote cancer progression
Study
EGAS00001003991